Granisetron transdermal patch: Clinical Trials

5 trials of Granisetron transdermal patch, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed, 1 recruiting, 1 unknown. 2 Phase 1, 1 Not applicable, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1
Not applicable1Terminated 1
Phase 31Unknown 1
Phase 41Recruiting 1

Follow Granisetron transdermal patch: new trials by email Literature Review of Granisetron transdermal patch trials Research Report on Granisetron transdermal patch

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess Bioequivalence and Adhesion Properties Between Two Granisetron Transdermal Patches.
Sancuso - Part 1, Sancuso - Part 2 - Healthy Volunteers
Phase 1CompletedKyowa Kirin, Inc.1342021-07-062024-06-14
Granisetron Transdermal Patch for Prophylaxis of Delayed CINV
Granisetron transdermal patch, Palonosetron, Aprepitant - Chemotherapy-induced Nausea and Vomiting (CINV)
Phase 3UnknownFudan University1402021-06-102021-06-03
BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron
Granisetron Transdermal Patch, Intravenous Dexamethasone, Ondansetron - Nausea With Vomiting Chemotherapy-Induced
Phase 4RecruitingUniversity of Illinois at Chicago902020-05-142025-11-12
Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy
granisetron transdermal system, fosaprepitant dimeglumine, laboratory biomarker analysis - Breast Cancer, Nausea
Phase 1TerminatedUniversity of Southern California292012-09-042017-11-17
Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
Adjuvant Therapy, Aprepitant, Carboplatin - Nausea and Vomiting, Ovarian Brenner Tumor
Not applicableTerminatedGynecologic Oncology Group42011-06-012018-05-22

Conditions studied

Nausea (3)  ·  Vomiting (3)  ·  Breast Neoplasms (1)  ·  Brenner Tumor (1)  ·  Fallopian Tube Neoplasms (1)  ·  Ovarian Neoplasms (1)

Sponsors

Fudan University (1)  ·  Gynecologic Oncology Group (1)  ·  Kyowa Kirin, Inc. (1)  ·  University of Illinois at Chicago (1)  ·  University of Southern California (1)

Countries

United States (4)

Top investigators

Agustin Garcia (1)  ·  Karen Sweiss, PharmD (1)  ·  Steven Plaxe (1)

Results publications

PMID 41520166

NIH funding

U10CA101165 (1)